Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver dysfunction in patients with hemophilia.

M W Hilgartner, P Giardina

    Scandinavian Journal of Haematology. Supplementum
    |January 1, 1977
    PubMed
    Summary

    Post-transfusion hepatitis and liver dysfunction are common in hemophilia patients receiving Factor VIII concentrate. Treatment regimens and concentrate amounts did not impact disease incidence, highlighting the need for close monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Are extremely high progesterone levels still an issue in IVF?

    Journal of endocrinological investigation·2016
    Same author

    Reasons to Eliminate Umbilical Cord Blood Units before Cryopreservation.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    `An account of an hemorrhagic disposition existing in certain families'.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Evidence for multidimensional resilience in adult patients with transfusion-dependent thalassemias: Is it more common than we think?

    Transfusion medicine (Oxford, England)·2016
    Same author

    A proteomic approach for the rapid, multi-informative and reliable identification of blood.

    The Analyst·2015
    Same author

    Self-assembly of hydrophobin protein rodlets studied with atomic force spectroscopy in dynamic mode.

    Langmuir : the ACS journal of surfaces and colloids·2011

    Area of Science:

    • Hepatology
    • Hematology
    • Transfusion Medicine

    Background:

    • Classical hemophilia patients often require Factor VIII concentrate, increasing transfusion risks.
    • Post-transfusion hepatitis and liver dysfunction are significant concerns in this population.

    Purpose of the Study:

    • To investigate the incidence of post-transfusion hepatitis and liver dysfunction in hemophilia patients.
    • To evaluate the impact of episodic versus prophylactic Factor VIII concentrate regimens on liver health.

    Main Methods:

    • Retrospective analysis of 54 classical hemophilia patients.
    • Assessment of biochemical liver function tests (SGOT, SGPT).
    • Hepatitis B surface antigen (HBsAg) and antibody (HBsAb) testing.

    Main Results:

    • 42.5% of patients showed persistent biochemical liver dysfunction.
    • 3.8% had persistent HBsAg positivity, while 90% developed HBsAb.
    • No significant difference in liver dysfunction incidence between episodic and prophylactic treatment groups.

    Conclusions:

    • Transfusion regimen and Factor VIII concentrate dosage did not affect liver disease incidence.
    • Close follow-up is crucial for managing chronic liver disease in hemophilia patients.
    • Further therapeutic strategies for post-transfusion liver complications are necessary.

    Related Experiment Videos